Identification of critical functional groups within binding pockets of G-protein-coupled receptors

Drugs of the Future

Volumn 21, Issue 5, 1996, Pages 521-527

  Cascieri, Margaret A ^a   Fong, Tung Ming ^a   Strader, Catherine D ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; 3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE; BETA 2 ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; L 159588; L 161644; L 709210; L 742311; N ACETYLTRYPTOPHAN 3,5 BIS(TRIFLUOROMETHYL)BENZYL ESTER; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; DRUG RECEPTOR BINDING; HUMAN; LIGAND BINDING; MOLECULAR CLONING; MOLECULAR INTERACTION; MUTAGENESIS; PROTEIN CONFORMATION; PROTEIN DETERMINATION; RECEPTOR AFFINITY; REVIEW; SEQUENCE ANALYSIS;

EID: 8944236086     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Dixon, R.A.F., Kobilka, B.K., Strader, D.J. et al. Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin. Nature 1986, 321: 75-9.
2. Dixon, R.A.F., Sigal, I S., Rands, E. et al. Ligand binding to the β-adrenergic receptor involves its rhodopsin-like core Nature 1987, 326: 73-7.
3. Probst, W.C., Snyder, L.A., Schuster, D.I., Brosius, J., Sealfon, S.C. Sequence alignment of the G-protein coupled receptor family. DNA Cell Biol 1992, 11: 1-20.
4. Henderson, R., Baldwin, J.M., Ceska, TA., Semlin, F., Beckmann, E., Downing, K H. Model for the structure of bacteriorhodopsin based on high resolution electron cryo-microscopy. J Mol Biol 1990, 213: 899-929.
5. Trump-Kallmeyer, S , Hoflack, J., Bruinvels, A., Hibert, M. Modeling of G-protein coupled receptors: Application to dopamine, adrenaline, serotonin, acetylcholine and mammalian opsin receptors. J Med Chem 1992, 35: 3448-62.
6. Pardo, L., Ballesteros, J.A., Osman, R., Weinstein, H. On the use of the transmembrane domain of bacteriorhodopsin as a template for modeling the three dimensional structure of guanine nucleotide binding regulatory protein-coupled receptors. Proc Natl Acad Sci USA 1992, 89: 4009-12
7. Lewell, X.Q. A model of the adrenergic beta-2 receptor and binding sites for agonist and antagonist. Drug Des Discov 1992, 9: 29-48.
8. Baldwin, J.M. The probable arrangement of the helices in G protein-coupled receptors. EMBO J 1993, 12: 1693-703.
9. 1 subtype, Gprotein coupled receptor. Chem Biol 1994, 1: 211-21.
10. Strader, C.D., Sigal, I.S., Register, R.B., Candelore, M.R., Rands, E., Dixon, R.A.F. Identification of residues required for ligand binding to the β-adrenergic receptor. Proc Natl Acad Sci USA 1989, 84: 4384-8.
11. Cascieri, M.A., Macleod, A.M., Underwood, D. et al. Characterization of the interaction of N-acyt-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor. J Biol Chem 1994, 269: 6587-91.
12. s and increase agonist affinity. J Biol Chem 1987, 262: 16439-43.
13. Strader, C.D., Candelore, M.R., Hill, W.S., Sigal, I.S , Dixon, R.A.F. Identification of two serine residues involved in agonist activation of the β-adrenergic receptor. J Biol Chem 1989, 264: 13572-8.
14. Dixon, R.A.F., Sigal, I.S., Strader, C.D. Structure-function analysis of the β-adrenergic receptor. Cold Spring Harbor Symp Quant Biol 1988, 53: 487-97.
15. Strader, C.D., Fong, T.M.,Tota, M.R., Underwood, D. Structure and function of G-protein-coupled receptors. Ann Rev Biochem 1994, 63: 101-32.
16. Fong, T.M., Yu, H., Huang, R-R.C., Strader, C-D. The extracellular domain of the neurokinin-1 receptor in required for high-affinity binding of peptides. Biochemistry 1992, 31: 11806-11.
17. Huang, R-R.C., Yu, H., Strader, C.D., Fong, T.M. Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor. Biochemistry 1994, 33: 3007-13.
18. Tsai-Morris, C.H., Buczko, E., Wang, W , Dufau, M.L. Intronic nature of the rat luteinizing hormone receptor gene defines a soluble receptor subspecies with hormone binding activity. J Biol Chem 1990, 265: 19385-8.
19. Graziano, M.P., Hey, P.J , Strader, C D. The amino terminal domain of the glucagon-like peptide receptor is a critical determinant of subtype specificity. Recept Channels 1995, 4: 9-17.
20. Fong, T.M., Yu, H., Cascieri, M.A., Underwood, D., Swain, C.J.. Strader, C.D. Interaction of glutamine-165 in the fourth transmembrane segment of the human neurokinin-1 receptor with quinuclidine antagonists. J Biol Chem 1994, 269: 14957-61.
21. Fong, T.M., Cascieri, M.A., Yu, H., Bansal, A., Swain, C., Strader, C.D. Amino-aromatic interaction between histidine-197 of the neurokinin-1 receptor and CP 96345. Nature 1993, 362: 350-3.
22. Fong, T.M., Yu, H., Cascieri, M.A., Underwood, D., Swain, C.J., Strader, C.D. The role of histidine-265 in antagonist binding to the neurokinin-1 receptor. J Biol Chem 1994, 269: 2728-32.
23. Cascieri, M.A., Shiao, L-L., Mills, S.G. et al. Characterization of the interaction of diacylpiperazine antagonists with the human neurokinin-1 receptor: Identification of a common binding site for structurally dissimilar antagonists. Mol Pharmacol 1995, 47: 660-5.
24. 1 receptor for substance P and a non-peptide antagonist. Nature 1993, 362: 345-8.
25. Gether, U., Nilsson, L., Lowe, J.A., Schwartz, T.W. Two specific residues at the top of transmembrane segment V and VI of the neurokinin-1 receptor involved in binding of the nonpeptide antagonist CP 96,345. J Biol Chem 1994, 269: 23959-64.
26. 2 receptors. Proc Natl Acad Sci USA 1993, 90: 6194-8.
27. Schambye, H.T., Hjorth, S.A., Bergsma, D.J., Sathe, G., Schwartz, T.W. Differentiation between binding sites forangiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors. Proc Natl Acad Sci USA 1994, 91: 7046-50.
28. Noda, K., Saad, Y., Kinoshita, A. et al. Tetrazoleandcarboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms. J Biol Chem 1995, 270: 2284-9.
29. Yamano, Y., Ohyama, K., Chaki, S., Guo, D-F, Inagami, T. Identificiation of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis. Biochem Biophys Res Commun 1992, 187: 1426-31.
30. 1 ). J Biol Chem 1995, 270: 14024-30.
31. 2 receptor allows discrimination between agonist and antagonist binding Sites. Mol Pharmacol 1993, 44: 934-9.
32. Beinborn, M., Lee, Y-M., McBride, E.W., Quinn, S.M., Kopin, A.S. A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists Nature 1993, 362: 348-50.
33. Kopin, A.S., McBride, E.W., Quinn, S.M., Kolakowski, L.F., Beinborn, M. The role of the cholecystokinin-B/gastrin receptor transmembrane domains in determining affinity for subtype-selective ligands. J Biol Chem 1995, 270: 5019-23.
34. Surratt, C.K , Johnson, P.S., Moriwaki, A. et al. μ-Opiate receptor. J Biol Chem 1994, 269: 20548-53.
35. Kong, H., Raynor, K., Yusuda, K. et al. A single residue, aspartic acid 95 in the δ opioid receptor specifies selective high affinity agonist binding. J Biol Chem 1993, 268: 23055-8.
36. Kong, H., Raynor, K., Yano, H., Takeda, J., Bell. G.I., Reisine, T. Agonists and antagonists bind to different domains of the cloned x opioid receptor. Proc Natl Acad Sci USA 1994, 91: 8042-6.
37. Fong, T.M., Yu, H., Strader, C.D. Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP 96,345 and RP 67580. J Biol Chem 1992, 267: 25668-71.
38. Wu, M.T., Ikeler, TJ., Ashton, W.T., Chang, R.S.L., Lotti, V.J., Greenlee, W.J. Synthesis and structure-activity relationships of a novel series of non-peptide AT-2-selective angiotensin II receptor antagonists. Bioorg Med Chem Lett 1993, 3: 2023-8.
39. Mills, S.G., Wu, M.T., MacCoss, M. et al. 1,4-Diacylpiperazine-2-(S)-[(N-aminoalkyl)carboxamides] as novel, potent substance P antagonists. Biorg Med Chem Lett 1993, 3: 2707-12.
40. 1) receptor. Science 1991, 251:435-7.
41. 1 antagonists I: 3-Benzyloxy-1-azabicyclo {2.2.2} octanes. Biorg Med Chem Lett 1993, 3: 1361-6
42. Harrison, T., Owens, A P., Williams, B.J. et al. Piperidine-ether based NK-1 antagonists 2: Investigation of the effect of N-substitution. Biorg Med Chem Lett 1995, 5: 209-12.
43. Hale, J.J., Mills, S.G., MacCoss, M. et al. L-742,694: A potent, orally active, morpholine-based human NK-1 receptor antagonist. J Med Chem 1996, 39: 1760-2.
44. Macleod, A.M., Merchant, K.M., Cascieri, M.A. et al. N-Acyltryptophan benzyl esters: Potent substance P receptor antagonists. J Med Chem 1993, 36: 2044-5.